{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:50:57Z","timestamp":1791827457119,"version":"4.3.4"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:00:00Z","timestamp":1791763200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-026-05828-z","type":"journal-article","created":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:26:47Z","timestamp":1791826007000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Associations between tissue stiffness, tumor response to transarterial chemoembolization and prognosis in hepatocellular carcinoma: insights from multifrequency 3D-magnetic resonance elastography"],"prefix":"10.1007","author":[{"given":"Jie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yali","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hehan","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7269-2101","authenticated-orcid":false,"given":"Bin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"5828_CR1","doi-asserted-by":"publisher","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA A Cancer J Clin. 2021;71:209\u201349.IF: 685.2 Q1 B1 https:\/\/doi.org\/10.3322\/caac.21660","DOI":"10.3322\/caac.21660"},{"key":"5828_CR2","doi-asserted-by":"publisher","unstructured":"Kudo M, Ueshima K, Ikeda M, Torimura T, Tanabe N, Aikata H, et al. Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial. Gut. 2020;69:1492\u2013501.IF: 24.6 Q1 B1https:\/\/doi.org\/10.1136\/gutjnl-2019-318934","DOI":"10.1136\/gutjnl-2019-318934"},{"key":"5828_CR3","doi-asserted-by":"publisher","unstructured":"Kim YR, Kim E, Kim HI, Han S, An J, Shim JH. Updated Network Meta-Analysis of First-Line Systemic Treatments for Advanced HCC: Consistent Role of TACE. Liver Cancer. 2026;15:117\u201334. IF: 10.5 Q1 B1https:\/\/doi.org\/10.1159\/000546697","DOI":"10.1159\/000546697"},{"key":"5828_CR4","doi-asserted-by":"publisher","unstructured":"Chen S, Peng Z, Zhang Y, Chen M, Li J, Guo R, et al. Lack of Response to Transarterial Chemoembolization for Intermediate-Stage Hepatocellular Carcinoma: Abandon or Repeat? Radiology. 2021;298:680\u201392. IF: 17.6 Q1 B1https:\/\/doi.org\/10.1148\/radiol.2021202289","DOI":"10.1148\/radiol.2021202289"},{"key":"5828_CR5","doi-asserted-by":"publisher","unstructured":"Li Z-W, Ren A-H, Yang D-W, Xu H, Wei J, Yuan C-W, et al. Preoperatively predicting early response of HCC to TACE using clinical indicators and MRI features. BMC Med Imaging. 2022;22:176. IF: 3.9 Q1 B3https:\/\/doi.org\/10.1186\/s12880-022-00900-8","DOI":"10.1186\/s12880-022-00900-8"},{"key":"5828_CR6","doi-asserted-by":"publisher","unstructured":"Kong C, Zhao Z, Chen W, Lv X, Shu G, Ye M, et al. Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE. Eur Radiol. 2021;31:7500\u201311. IF: 6.0 Q1 B2https:\/\/doi.org\/10.1007\/s00330-021-07910-0","DOI":"10.1007\/s00330-021-07910-0"},{"key":"5828_CR7","doi-asserted-by":"publisher","unstructured":"Ma J-Y, Wei W, Wang Y-X, Zhao Z-Y, Xiong Z-Y, Mei J, et al. Mitochondrial Gene Scoring System: Predicting Prognosis and Precision Therapy for TACE Non-Response in Hepatocellular Carcinoma Patients. J Cancer. 2025;16:629\u201347. IF: 3.4 Q2 B3https:\/\/doi.org\/10.7150\/jca.103946","DOI":"10.7150\/jca.103946"},{"key":"5828_CR8","doi-asserted-by":"publisher","unstructured":"Zhang J, Yan C, Wang Y, Gao M, Han J, Zhang M, et al. Quantitative Magnetic Resonance Imaging Methods for the Assessment and Prediction of Treatment Response to Transarterial Chemoembolization in Hepatocellular Carcinoma. Academic Radiology. 2025;32:6503\u201313.IF: 4.7 Q1 B2 https:\/\/doi.org\/10.1016\/j.acra.2025.02.042","DOI":"10.1016\/j.acra.2025.02.042"},{"key":"5828_CR9","doi-asserted-by":"publisher","unstructured":"Chen J, Wu Z, Zhang Z, Chen Y, Yin M, Ehman RL, et al. Apparent diffusion coefficient and tissue stiffness are associated with different tumor microenvironment features of hepatocellular carcinoma. Eur Radiol [Internet]. 2024 [cited 2024 Aug 1]; IF: 6.0 Q1 B2https:\/\/doi.org\/10.1007\/s00330-024-10743-2","DOI":"10.1007\/s00330-024-10743-2"},{"key":"5828_CR10","doi-asserted-by":"publisher","unstructured":"Gordic S, Ayache JB, Kennedy P, Besa C, Wagner M, Bane O, et al. Value of tumor stiffness measured with MR elastography for assessment of response of hepatocellular carcinoma to locoregional therapy. Abdom Radiol. 2017;42:1685\u201394. IF: 2.3 Q2 B3https:\/\/doi.org\/10.1007\/s00261-017-1066-y","DOI":"10.1007\/s00261-017-1066-y"},{"key":"5828_CR11","doi-asserted-by":"publisher","unstructured":"Cihan A, Holko K, Wei L, Vos HJ, Debbaut C, Caenen A, et al. Effect of interstitial fluid pressure on shear wave elastography: an experimental and computational study. Phys Med Biol. 2024;69. IF: 3.1 Q2 B3https:\/\/doi.org\/10.1088\/1361-6560\/ad2d80","DOI":"10.1088\/1361-6560\/ad2d80"},{"key":"5828_CR12","doi-asserted-by":"publisher","unstructured":"Zhao D, Liu Y, Liu Z, Guo X, Zhang L, Zhang H, et al. Hyaluronidase optimizes TACE in hepatocellular carcinoma by remodeling tumor stroma and enhancing chemotherapy penetration. Int J Biol Macromol. 2026;339:149868.IF: 8.7 Q1 B2 https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.149868","DOI":"10.1016\/j.ijbiomac.2025.149868"},{"key":"5828_CR13","doi-asserted-by":"publisher","unstructured":"Chen R, Kong W, Gan Y, Ge N, Chen Y, Ding H, et al. Tumour stiffness associated with tumour response to conventional transarterial chemoembolisation for hepatocellular carcinoma: preliminary findings. Clinical Radiology. 2019;74:814.e1-814.e7. IF: 2.0 Q3 B4https:\/\/doi.org\/10.1016\/j.crad.2019.07.008","DOI":"10.1016\/j.crad.2019.07.008"},{"key":"5828_CR14","doi-asserted-by":"publisher","unstructured":"Kennedy P, Lewis S, Bane O, Hectors SJ, Kim E, Schwartz M, et al. Early effect of 90Y radioembolisation on hepatocellular carcinoma and liver parenchyma stiffness measured with MR elastography: initial experience. Eur Radiol. 2021;31:5791\u2013801. IF: 6.0 Q1 B2https:\/\/doi.org\/10.1007\/s00330-020-07636-5","DOI":"10.1007\/s00330-020-07636-5"},{"key":"5828_CR15","doi-asserted-by":"publisher","unstructured":"Xiao G, Zhu S, Xiao X, Yan L, Yang J, Wu G. Comparison of laboratory tests, ultrasound, or magnetic resonance elastography to detect fibrosis in patients with nonalcoholic fatty liver disease: A meta-analysis. Hepatology. Baltimore, Md.; 2017;66:1486\u2013501.IF: 18.0 Q1 B1 https:\/\/doi.org\/10.1002\/hep.29302","DOI":"10.1002\/hep.29302"},{"key":"5828_CR16","doi-asserted-by":"publisher","unstructured":"Liu D, Chen J, Zhang Y, Dai Y, Yao X. Magnetic resonance elastography-derived stiffness: potential imaging biomarker for differentiation of benign and malignant pancreatic masses. Abdom Radiol (NY). 2023;48:2604\u201314. IF: 2.3 Q2 B3https:\/\/doi.org\/10.1007\/s00261-023-03956-4","DOI":"10.1007\/s00261-023-03956-4"},{"key":"5828_CR17","doi-asserted-by":"publisher","unstructured":"Zhang L, Li M, Zhu J, Zhang Y, Xiao Y, Dong M, et al. The value of quantitative MR elastography-based stiffness for assessing the microvascular invasion grade in hepatocellular carcinoma. Eur Radiol. 2022;IF: 6.0 Q1 B2 https:\/\/doi.org\/10.1007\/s00330-022-09290-5","DOI":"10.1007\/s00330-022-09290-5"},{"key":"5828_CR18","doi-asserted-by":"publisher","unstructured":"Wang J, Shan Q, Liu Y, Yang H, Kuang S, He B, et al. 3D MR Elastography of Hepatocellular Carcinomas as a Potential Biomarker for Predicting Tumor Recurrence: HCC Evaluation With MR Elastography. J Magn Reson Imaging. 2019;49:719\u201330. IF: 4.3 Q1 B2https:\/\/doi.org\/10.1002\/jmri.26250","DOI":"10.1002\/jmri.26250"},{"key":"5828_CR19","doi-asserted-by":"publisher","unstructured":"Chen J, Chen J, Heilman JA, Glaser KJ, Grimm RC, Owusu N, et al. Abdominal MR elastography with multiple driver arrays: performance and repeatability. Abdom Radiol (NY). 2023;48:1945\u201354. IF: 2.3 Q2 B3https:\/\/doi.org\/10.1007\/s00261-023-03866-5","DOI":"10.1007\/s00261-023-03866-5"},{"key":"5828_CR20","doi-asserted-by":"publisher","unstructured":"Reiberger T. The Value of Liver and Spleen Stiffness for Evaluation of Portal Hypertension in Compensated Cirrhosis. Hepatol Commun. 2022;6:950\u201364.IF: 6.0 Q1 B2 https:\/\/doi.org\/10.1002\/hep4.1855","DOI":"10.1002\/hep4.1855"},{"key":"5828_CR21","doi-asserted-by":"publisher","unstructured":"Buechter M, Manka P, Theysohn JM, Reinboldt M, Canbay A, Kahraman A. Spleen stiffness is positively correlated with HVPG and decreases significantly after TIPS implantation. Dig Liver Dis. 2018;50:54\u201360. IF: 4.9 Q1 B2https:\/\/doi.org\/10.1016\/j.dld.2017.09.138","DOI":"10.1016\/j.dld.2017.09.138"},{"key":"5828_CR22","doi-asserted-by":"publisher","unstructured":"Manduca A, Bayly PJ, Ehman RL, Kolipaka A, Royston TJ, Sack I, et al. MR elastography: Principles, guidelines, and terminology. Magn Reson Med. 2021;85:2377\u201390. IF: 3.2 Q2 B3https:\/\/doi.org\/10.1002\/mrm.28627","DOI":"10.1002\/mrm.28627"},{"key":"5828_CR23","doi-asserted-by":"publisher","unstructured":"Li J, Sehrawat TS, Chen J, Hilscher MB, Glaser KJ, Arab JP, et al. Quantitative assessment of portal hypertension with bi-parametric dual-frequency hepatic MR elastography in mouse models. Eur Radiol. 2021;31:2303\u201311. IF: 3.2 Q2 B3https:\/\/doi.org\/10.1007\/s00330-020-07341-3","DOI":"10.1007\/s00330-020-07341-3"},{"key":"5828_CR24","doi-asserted-by":"publisher","unstructured":"Du B, Qi X, Ma Y, Pan C, Wu Q, Niu M, et al. Multifrequency Multiparameter Magnetic Resonance Elastography Applied to an In Vivo Porcine Model for Assessing Portal Hypertension. Portal Hypertension & Cirrhosis. 2026;5:54\u201364. IF: 1.3 Q4 NAhttps:\/\/doi.org\/10.1002\/poh2.70027","DOI":"10.1002\/poh2.70027"},{"key":"5828_CR25","doi-asserted-by":"publisher","unstructured":"Jiang N, Zhang W, Peng Z, Liu C, Xiao Y-D, Yang W-Z, et al. Impact of Procedural Quality on Outcomes of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Multicenter Study. Liver Cancer. 2026;IF: 10.5 Q1 B1 https:\/\/doi.org\/10.1159\/000550734","DOI":"10.1159\/000550734"},{"key":"5828_CR26","doi-asserted-by":"publisher","unstructured":"Dajti E, Ravaioli F, Zykus R, Rautou P-E, Elkrief L, Grgurevic I, et al. Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis. Lancet Gastroenterol Hepatol. 2023;8:816\u201328. IF: 39.1 Q1 B1https:\/\/doi.org\/10.1016\/S2468-1253(23)00150-4","DOI":"10.1016\/S2468-1253(23)00150-4"},{"key":"5828_CR27","doi-asserted-by":"publisher","unstructured":"Yiyi M, Xiaoqin Q, Lei Z. Spleen Stiffness on Magnetic Resonance Elastography for the Detection of Portal Hypertension: A Systematic Review and Meta-Analysis. Iran J Public Health. 2022;51:1925\u201335. IF: 1.9 Q3 B4https:\/\/doi.org\/10.18502\/ijph.v51i9.10548","DOI":"10.18502\/ijph.v51i9.10548"},{"key":"5828_CR28","doi-asserted-by":"publisher","unstructured":"Hu X, Huang X, Hou J, Ding L, Su C, Meng F. Diagnostic accuracy of spleen stiffness to evaluate portal hypertension and esophageal varices in chronic liver disease: a systematic review and meta-analysis. Eur Radiol. 2021;31:2392\u2013404. IF: 6.0 Q1 B2https:\/\/doi.org\/10.1007\/s00330-020-07223-8","DOI":"10.1007\/s00330-020-07223-8"},{"key":"5828_CR29","doi-asserted-by":"publisher","unstructured":"Takuma Y, Nouso K, Morimoto Y, Tomokuni J, Sahara A, Takabatake H, et al. Portal Hypertension in Patients with Liver Cirrhosis: Diagnostic Accuracy of Spleen Stiffness. Radiology. 2016;279:609\u201319. IF: 17.6 Q1 B1https:\/\/doi.org\/10.1148\/radiol.2015150690","DOI":"10.1148\/radiol.2015150690"},{"key":"5828_CR30","doi-asserted-by":"publisher","unstructured":"Choi JW, Chung JW, Lee DH, Kim H-C, Hur S, Lee M, et al. Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma. Eur Radiol. 2018;28:2184\u201393. IF: 6.0 Q1 B2https:\/\/doi.org\/10.1007\/s00330-017-5145-9","DOI":"10.1007\/s00330-017-5145-9"},{"key":"5828_CR31","doi-asserted-by":"publisher","unstructured":"Kim NH, Lee T, Cho YK, Kim BI, Kim HJ. Impact of clinically evident portal hypertension on clinical outcome of patients with hepatocellular carcinoma treated by transarterial chemoembolization. J Gastroenterol Hepatol. 2018;33:1397\u2013406. IF: 3.5 Q2 B3https:\/\/doi.org\/10.1111\/jgh.14083","DOI":"10.1111\/jgh.14083"},{"key":"5828_CR32","doi-asserted-by":"publisher","unstructured":"M\u00fcller L, Hahn F, M\u00e4hringer-Kunz A, Stoehr F, Gairing SJ, Foerster F, et al. Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization. United European Gastroenterol J. 2022;10:41\u201353. IF: 6.4 Q1 B2https:\/\/doi.org\/10.1002\/ueg2.12188","DOI":"10.1002\/ueg2.12188"},{"key":"5828_CR33","doi-asserted-by":"publisher","unstructured":"Hou S, Hua S, Cui K, Liu F, Ding K, Yuan J. The course and prognostic value of tumor stiffness detected by ultrasound elastography for transarterial chemoembolization of hepatocellular carcinoma. Quant Imaging Med Surg. 2023;13:3962\u201372. IF: 2.8 Q2 B3https:\/\/doi.org\/10.21037\/qims-22-292","DOI":"10.21037\/qims-22-292"},{"key":"5828_CR34","doi-asserted-by":"publisher","unstructured":"Park S, Yoon JH, Lee DH, Lim WH, Lee JM. Tumor Stiffness Measurements on MR Elastography for Single Nodular Hepatocellular Carcinomas Can Predict Tumor Recurrence After Hepatic Resection. J Magn Reson Imaging. 2021;53:587\u201396. IF: 4.3 Q1 B2https:\/\/doi.org\/10.1002\/jmri.27359","DOI":"10.1002\/jmri.27359"},{"key":"5828_CR35","doi-asserted-by":"publisher","unstructured":"Lv Z, Cai X, Weng X, Xiao H, Du C, Cheng J, et al. Tumor-stroma ratio is a prognostic factor for survival in hepatocellular carcinoma patients after liver resection or transplantation. Surgery. 2015;158:142\u201350. IF: 3.2 Q1 B2https:\/\/doi.org\/10.1016\/j.surg.2015.02.013","DOI":"10.1016\/j.surg.2015.02.013"},{"key":"5828_CR36","doi-asserted-by":"publisher","unstructured":"Wang D, Luo J, Tao Y. Tumor-stroma ratio predicts prognosis and PD-L1 expression in hepatocellular carcinoma. BMC Cancer. 2023;23:434. IF: 4.1 Q2 B3https:\/\/doi.org\/10.1186\/s12885-023-10859-6","DOI":"10.1186\/s12885-023-10859-6"},{"key":"5828_CR37","doi-asserted-by":"publisher","unstructured":"Kang HJ, Oh J-H, Chun S-M, Kim D, Ryu Y-M, Hwang HS, et al. Immunogenomic landscape of hepatocellular carcinoma with immune cell stroma and EBV-positive tumor-infiltrating lymphocytes. J Hepatol. 2019;71:91\u2013103. IF: 40.1 Q1 B1https:\/\/doi.org\/10.1016\/j.jhep.2019.03.018","DOI":"10.1016\/j.jhep.2019.03.018"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05828-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-026-05828-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-026-05828-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:26:48Z","timestamp":1791826008000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-026-05828-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":37,"alternative-id":["5828"],"URL":"https:\/\/doi.org\/10.1007\/s00261-026-05828-z","relation":{},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]},"assertion":[{"value":"6 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}